Yuelei Shen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Taohong siwu decoction alleviates hand-foot skin reaction by regulating RAGE-mediated keratinocyte apoptosis and autophagy.
Journal: Journal of ethnopharmacology
Published: December 09, 2025
Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts.
Journal: Human vaccines & immunotherapeutics
Published: April 24, 2025
A Standardized Protocol for Mouse Longevity Studies in Preclinical Drug Development.
Journal: Aging and disease
Published: April 14, 2025
Efficacy and safety of furmonertinib in patients with EGFR‑mutant advanced lung adenocarcinoma after failure of multiple lines of therapy: A single‑center retrospective study.
Journal: Oncology letters
Published: January 21, 2025
A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs.
Journal: Investigational new drugs
Published: November 23, 2024
Lung squamous cell carcinoma with metastases in the left atrium and left ventricle responds to treatment with immunotherapy: A case report.
Journal: Oncology letters
Published: July 11, 2024
The establishment of B cell-deficient Igh-J KO mouse model by gene editing and efficacy evaluation.
Journal: International immunopharmacology
Published: November 16, 2022
A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain.
Journal: Briefings in bioinformatics
Published: November 27, 2021
Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective.
Journal: Antibody therapeutics
Published: August 19, 2021
Antibody heavy chain CDR3 length-dependent usage of human IGHJ4 and IGHJ6 germline genes.
Journal: Antibody therapeutics
Published: April 26, 2021
Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants.
Journal: Cell discovery
Published: April 11, 2021
Last Updated: 09/26/2026